United StatesÚltimas notícias

Crypto funds attracted $47.2 billion in 2025, with strong altcoin inflows offsetting a sharp slowdown in Bitcoin demand.

New research cited by an ESG expert challenges long-held claims about Bitcoin mining’s environmental and energy impact.

Drake has been named in a RICO lawsuit accusing him of using crypto casino Stake to hide payments linked to music botting.

Goldman Sachs has upgraded Coinbase on stronger product momentum while cutting its outlook for rival trading platform eToro.

Polymarket has teamed up with Parcl to bring housing price indexes into prediction markets for the first time.

Jollibee Foods Corp. shares saw their largest single-day rally in 18 years on Tuesday after the Philippine fast-food giant announced a transformative plan to spin off its international business and list it on a U.S. stock exchange.

The move is designed to decouple the company’s high-growth global brands from its stable, cash-generative domestic operations, providing investors with "targeted exposure" to two distinct equity stories.

Advanced Micro Devices (NASDAQ:AMD) introduced a sweeping new portfolio of x86 processors at CES 2026, targeting the burgeoning "physical AI" market.

The new Ryzen AI Embedded P100 and X100 series are designed to bring high-performance, low-latency intelligence to automotive cockpits, industrial robotics, and autonomous systems, moving complex decision-making from the cloud to the device itself.

Moderna (NASDAQ:MRNA) officially moved to challenge the multi-billion-dollar seasonal influenza market today, submitting marketing authorization applications for its investigational vaccine, mRNA-1010, to regulators in the U.S., Europe, Canada, and Australia.

UMH Properties (NYSE:UMH) reported a transformative 2025 in its preliminary year-end update, fueled by a record expansion of its rental portfolio and a comprehensive refinancing of its debt stack.

Zenas BioPharma (NASDAQ:ZBIO), a clinical-stage global biopharmaceutical company focused on developing transformative immunology-based therapies for autoimmune diseases, today announced positive topline results from the Phase 3 INDIGO registrational trial evaluating obexelimab in patients with Immunoglobulin G4-Related Disease (IgG4-RD).

Neumora Therapeutics (NASDAQ:NMRA), a clinical-stage biopharmaceutical company focused on developing novel therapies for neuropsychiatric disorders and neurodegenerative diseases, today reported positive topline results from a Phase 1b signal-seeking study evaluating NMRA-511 as a potential treatment for agitation in patients with Alzheimer's disease.

RedHill Biopharma (NASDAQ:RDHL) is positioning its proprietary oral drug, RHB-102 (Bekinda), as a critical solution to the "discontinuation crisis" facing the blockbuster weight-loss drug market.